Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A multicenter, single arm, open-label study to assess the effect of omalizumab used as add-on therapy to standard asthma medications on asthma-related quality of life in Korean patientswith severe persistent allergic asthma: Korean-INNOVATE
- Authors
- 윤호주
- Issue Date
- 28-May-2010
- Place
- 서울 쉐라톤워커힐호텔
- Conference Name
- 2010 KAAACI Spring Congress & Korea-Japan Allergy Symposium
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.